Schedule 13G ownership disclosure
Inmune Bio Inc
Security class unavailable · CUSIP: 45782T105
Event date: 2021-07-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 909,091
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-21-007427
- Form type
- SC 13G
- Filer
- Altium Capital Management LLC
- CIK
- CIK 1746382
- Filed
- Jul 19, 2021
- Reporting period
- Jul 14, 2021
- Description
- Schedule 13G beneficial ownership